ARZNEIMITTEL ENTHALTEND LAMOTRIGIN

Patent europeic · EP0833640 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0833640
Numer da la dumonda
EP96923914
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
20-06-1996
Publitgà
08-04-1998
Concedì
04-12-2002
Stritgà
30-06-2009
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/53 (2006.01)
A61K 9/14 (2006.01)
A61K 9/19 (2006.01)
Prioritad
GB 9512854 23.06.1995
Dumonda PCT
PCT/EP1996/002759 20.06.1996
Publicaziun PCT
WO1997/000681 09.01.1997
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-01-2010

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.01.2010

  2. 15-10-2007

    Adressa midada

    Representative
    E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in +pat+ No 19 in 2007

  3. 14-03-2003

    Represchentant inscrit

    Representative
    E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich

    Published in +pat+ No 5 in 2003

  4. 13-12-2002

    Concedì

    Published in +pat+ No 23 in 2002

Partidas

Inventur

FLOYD, Alison, Green-Glaxo Wellcome Inc.

Research Triangle Park, NC 27709, US

JAIN, Sunil-Glaxo Wellcome Inc.

Research Triangle Park, NC 27709, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.